Global Sexually Transmitted Disease (STD ) Drug Market Research Report 2019 (Includes Business Impact of COVID-19)
- TBI291928
- March 18, 2019
- Global
- 97 pages
- QY Market Research
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Sexually Transmitted Disease (STD ) Drug market.
Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Sexually Transmitted Disease (STD ) Drug market."
Sexually transmitted diseases (STDs), also referred as venereal diseases are infections that can pass from person to person during sex. These diseases are caused mainly due to bacteria, viruses, and / or parasites. Sexually transmitted diseases (STDs) often go undiagnosed because these infections usually do not exhibit visual symptoms.
The global Sexually Transmitted Disease (STD ) Drug market is valued at 14300 million US$ in 2018 is expected to reach 33300 million US$ by the end of 2025, growing at a CAGR of 11.2% during 2019-2025.
This report focuses on Sexually Transmitted Disease (STD ) Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Sexually Transmitted Disease (STD ) Drug market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Pfizer
Roche
Bayer
Eli Lilly
Johnson & Johnson
Bristol-Myers Squibb
AbbVie
Gilead Sciences
GlaxoSmithKline
Merck
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Antibiotics
Antiviral
Vaccines
Segment by Application
Hospital
Clinic
Table of Contents
Executive Summary
1 Sexually Transmitted Disease (STD ) Drug Market Overview
1.1 Product Overview and Scope of Sexually Transmitted Disease (STD ) Drug
1.2 Sexually Transmitted Disease (STD ) Drug Segment by Type
1.2.1 Global Sexually Transmitted Disease (STD ) Drug Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Antibiotics
1.2.3 Antiviral
1.2.4 Vaccines
1.3 Sexually Transmitted Disease (STD ) Drug Segment by Application
1.3.1 Sexually Transmitted Disease (STD ) Drug Consumption Comparison by Application (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Sexually Transmitted Disease (STD ) Drug Market by Region
1.4.1 Global Sexually Transmitted Disease (STD ) Drug Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Sexually Transmitted Disease (STD ) Drug Market Size
1.5.1 Global Sexually Transmitted Disease (STD ) Drug Revenue (2014-2025)
1.5.2 Global Sexually Transmitted Disease (STD ) Drug Production (2014-2025)
2 Global Sexually Transmitted Disease (STD ) Drug Market Competition by Manufacturers
2.1 Global Sexually Transmitted Disease (STD ) Drug Production Market Share by Manufacturers (2014-2019)
2.2 Global Sexually Transmitted Disease (STD ) Drug Revenue Share by Manufacturers (2014-2019)
2.3 Global Sexually Transmitted Disease (STD ) Drug Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Sexually Transmitted Disease (STD ) Drug Production Sites, Area Served, Product Types
2.5 Sexually Transmitted Disease (STD ) Drug Market Competitive Situation and Trends
2.5.1 Sexually Transmitted Disease (STD ) Drug Market Concentration Rate
2.5.2 Sexually Transmitted Disease (STD ) Drug Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Sexually Transmitted Disease (STD ) Drug Production Market Share by Regions
3.1 Global Sexually Transmitted Disease (STD ) Drug Production Market Share by Regions
3.2 Global Sexually Transmitted ...
| read more...
Related Reports
